Seoul, South Korea

Jae Ho Cheong

This inventor holds 8 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignees: Haimbio Co., Ltd., Yonsei University, Cellaster, Inc.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Ho Cheong. Retrieved from https://idiyas.com/inventor/jae-ho-cheong-60x9w7sc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Jae Ho Cheong in Cancer Research**

Introduction

Jae Ho Cheong is a prominent inventor based in Seoul, South Korea, renowned for his contributions to cancer research through his innovative patents. With a total of six patents to his name, Cheong has been pioneering advancements in pharmaceutical science and cancer treatment modalities.

Latest Patents

Among his notable inventions, Cheong's recent patents include:

1. **Diketopiperazine derivatives as calcium ATPase inhibitor for enhancing anticancer activity** - This invention pertains to a novel compound and a pharmaceutical composition that bolsters anticancer activity. The composition features a compound represented by a specific formula or its pharmaceutically acceptable salts, enhancing the effectiveness of anticancer agents or radiation while inducing proliferation inhibition and death of cancer cells, ultimately aiding in cancer treatment.

2. **System for predicting prognosis and benefit from adjuvant chemotherapy for patients with stage II and III gastric cancer** - This innovative system encompasses an algorithm capable of predicting prognosis and chemotherapy responsiveness. It utilizes quantitative analysis of mRNA expression levels from a marker gene group and a reference gene group in advanced gastric cancer, supplementing information necessary for determining optimal treatment strategies for gastric cancer patients.

Career Highlights

Jae Ho Cheong has held significant roles in leading companies such as Haimbio Co., Ltd. and Immunomet Therapeutics Inc. His career is marked by a commitment to developing groundbreaking technologies aimed at improving patient outcomes in oncology.

Collaborations

Throughout his career, Cheong has collaborated with esteemed colleagues including Ki Cheong Park and Seok Gu Kang. These collaborations have contributed to the refinement and execution of his innovative ideas, furthering the impact of his work in medical science.

Conclusion

Jae Ho Cheong's innovative spirit and dedication to cancer research have led to significant advancements in the field. His recent patents not only demonstrate his expertise but also showcase his commitment to improving the lives of cancer patients. As his career progresses, Cheong continues to embody the essence of a forward-thinking inventor, making strides that have the potential to transform cancer treatment approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…